UK calls for fair treatment of BP in appeals court

Posted on Wednesday, September 17th, 2014 at 10:47 am    

The government of the United Kingdom suggested to the United States Supreme Court that it review appeals court rulings against London-based oil magnate BP Plc over the 2010 Gulf of Mexico oil spill fiasco that resulted in one of the most massive class action cases in America, Reuters reported on September 7.

The British government stated that the manner in which BP is being treated by the American courts is undermining the trust necessary for healthy and fruitful international commerce.

BP’s offshore oil rig Deepwater Horizon, which is located off the coast of Louisiana, exploded on April 20, 2010, causing oil to spew into the Gulf of Mexico. The company, now supported by the U.K., believes that compensation is now unfairly extending to parties who were not affected by this incident.

If you live near the Gulf area and your business and way of life has been affected by the massive 2010 Gulf of Mexico oil spill, you have the right to be compensated for your troubles. Turn to the attorneys at Williams Khekher by dialing (800) 220-9341 to acquire legal assistance today.

Risperdal and the risk of pancreatitis

Posted on Tuesday, September 16th, 2014 at 11:39 am    

Although Risperdal has been approved to treat symptoms of autism, bipolar disorder, and schizophrenia, several clinical studies have suggested the drug may cause severe side-effects. In fact, a 2003 article published in Pharmacotherapy noted an increased incidence of pancreatitis among various atypical antipsychotics, including Risperdal.

Pancreatitis, or the inflammation of the pancreas, occurs when digestive enzymes are activated in the pancreas instead of the small intestine. Characteristic symptoms are abdominal pain that may radiate to the back, nausea and vomiting. Due to its many life-threatening complications, such as kidney failure, severe lung dysfunction, dehydration, and shock, pancreatitis is regarded a medical emergency that requires immediate hospitalization and monitored care.

Our dedicated team of pharmaceutical defect attorneys at Williams Kherkher have been helping Risperdal victims file claims against the drug manufacturer if they suffer from complications caused by this potentially harmful medication. To see if we can put our experience to work for you, call our offices at (800) 220-9341 today.

New hip replacement surgery methods

Posted on Friday, September 12th, 2014 at 9:12 am    

According to Dr. Jordan Schaeffer of the Salt Lake Regional Medical Center in Salt Lake City, Utah, people who are worried about undergoing potentially majorly invasive hip implant operations can opt for less muscle-intensive procedures, Good4Utah reported on August 12.

Schaeffer noted that while traditional hip implant surgeries are generally successful and bring about medically fulfilling results for the hip implant patient, newer techniques involving muscle- and tissue-sparing approaches are also very promising.

An example of this procedure is the anterior hip replacement surgery. This is usually performed by cutting an incision on the patient’s side or back. This is done to avoid involving the major muscle groups and only involves the joint of the muscles.

Although hip implant methods are constantly evolving, the attorneys at Williams Kherkher know that many patients have suffered dangerous side effects from DePuy hip implants in particular. If you or a loved one has experienced this, call our Houston offices at 800-220-9341 today.

Detroit Lions’ Kyle Van Noy may have sports hernia

Posted on Thursday, September 11th, 2014 at 12:38 pm    

The Detroit Lions are in danger of opening the season without their rookie linebacker Kyle Van Noy due to severe abdominal pain that has yet to be diagnosed.

Van Noy said he fears that his latest injury could be a sports hernia, a condition that can take him out of the game for four to six weeks. He cannot determine the exact incident that caused the injury, but his condition has recently worsened, until he finally had to be benched during practices on Thursday, August 21.

Coach Jim Caldwell did not comment on questions regarding the possibility that this may be a long-term injury, thus affecting his status in the team.

Tahir Whitehead started the season as strong-side linebacker, bypassing Ashlee Palmer and the injured Van Noy.

Your doctor may recommend different courses of treatment for a hernia depending on your individual situation and the severity of the condition. However, be aware that the AlloDerm hernia patch has been associated with negative side effects, such as a recurrence, infection, and rejection. Contact our attorneys of Williams Kherkher today at (800) 220-9341 to pursue legal action if you have had the same issues with your AlloDerm use.

The difference between hemodialysis and peritoneal dialysis

Posted on Wednesday, September 10th, 2014 at 11:29 am    

Dialysis is defined as the process of taking away waste products and excess water from the body. This is often a necessary procedure for those suffering from chronic kidney disease or related problems.

Hemodialysis is the process of removing electrolytes, waste products, and fluids from the body through the circulatory system, meaning that blood is pumped from the artery into the dialysis machine and back.

On the other hand, peritoneal dialysis is the removal of electrolytes, waste products, and fluids from the body using the peritoneum – the membrane that forms the lining of the abdominal cavity – as a diffusing membrane. A solution called a dialysate (which contains water, glucose, and normal serum electrolytes) would be inserted into the peritoneal cavity using a catheter.

Some dialysis treatments involve the use of dialysate GranuFlo, which unfortunately may result in serious side effects, such as low blood pressure or sudden death. If you or a loved one has suffered as the result of GranuFlo, the attorneys at Williams Kherkher may help you pursue negligent drug manufacturers for financial compensation. Call our offices today at 800-220-9341 to learn more.

FDA approve drug to treat blood clots

Posted on Wednesday, September 10th, 2014 at 9:52 am    

A drug was recently approved by the US Food and Drug Administration (FDA) to treat blood clots, an article of Uncover California stated on August 22.

Reports said anticoagulant drug Eliquis (apixaban) was approved by the FDA to treat pulmonary embolism (PE) and deep vein thrombosis (DVT) with can result in a number of serious conditions such as heart attack, stroke, and pulmonary embolism. However, there are risks associated with taking and discontinuing the drug, so be sure to consult a medical professional to see if you are a good candidate for this treatment. Eliquis’ approval was made public by Bristol-Myers Squibb and Pfizer Inc.

Unfortunately many women suffer from deep vein thrombosis and pulmonary embolism as a result of taking Yasmin or Yaz contraceptives. If you develop either of these conditions, it is important to get a lawyer’s help in order to fund your treatment. Find out how the lawyers of Williams Kherkher may possibly help you recover your losses today by calling (800) 220-9341.

No elevated risk of complications from VT treatment in children with cleft

Posted on Wednesday, September 10th, 2014 at 9:19 am    

A recent study in Scotland suggests that complications from ventilation tube (VT) treatment in children with cleft lip and palate (CLP) are not any more common than other populations, MedicalXpress reported on August 28.

Researchers at Royal Hospital for Sick Children in Glasgow used VT to treat for chronic ear infections and related problems in 60 children with clefts and compared the rate of complications with a control group. The researchers found that only an average of 2.4 percent of children with clefts had complications with VT, while those without clefts had a 3.2 percent rate of complication. Since chronic ear infections are so common in a population already vulnerable to speech and developmental delays, some specialists, like Sr. Ian Smillie, M.R.C.S. Ed., are recommending VT sooner and in more cases.

Dealing with chronic ear infections are only one obstacle arising from cleft lip and palate. Although the cause of CLP is unknown, there is a higher risk of this condition when the baby was exposed to Topamax in utero. If you think your loved one developed CLP due to Topamax use, the lawyers of Williams Kherkher may work for you. Find out how we may possibly help you recover your losses today by calling (800) 220-9341.

Increased risk of craniosynostosis with Zoloft use

Posted on Thursday, September 4th, 2014 at 1:49 pm    

Craniosynostosis is a condition where the bones in an infant’s skull fuses together prematurely causing abnormal cranial formation which may lead to other widespread impairments. This birth defect can be a result of certain genetic disorders, biochemical factors, or environmental agents such as ingesting SSRIs like Zoloft during pregnancy.

Craniosynostosis may cause facial and head deformities that can affect breathing, feeding, and speech. Intercranial pressure as a result of this condition may also cause vision loss, neurobehavioral issues, headaches, and seizures among other problems. Severe cases might require invasive surgery that can be risky and financially costly.

Pregnant women who took the antidepressant Zoloft were found to be at a 2.5 times higher risk of having a child with craniosynostosis. If you are part of a family affected by this condition potentially as a result of an SSRI, contact our attorneys at Williams Kherkher for information about your legal recourse at (800)220-9341.

Williams Kherkher to Participate in 2014 Harris County Labor Day Celebration

Posted on Thursday, August 28th, 2014 at 2:16 pm    

This weekend, Williams Kherkher is proud to be a Silver Sponsor at the 2014 Harris County Labor Day Weekend Celebration. The event will be held on Friday and Saturday at the Pasadena Fairgrounds and will feature an array of events throughout the weekend. We are excited to join in on the event in support of our union friends.

During the Labor Day weekend celebration, the whole family can participate in the BBQ cook-off, a raffle benefiting the Muscular Dystrophy Association, live music, a petting zoo, and pony rides. There are plenty of ways to get involved in the celebration and show your support for Houston’s workforce. Facilitators are still looking for volunteers to help with various projects during the celebration. To learn more about how you can get involved, click here.

The team at Williams Kherkher is committed to supporting the Houston community. Come out and join in the fun this weekend!





Fed. gov’t to pay almost $1M for costs related to BP oil spill trial

Posted on Monday, August 25th, 2014 at 8:57 am    

United States Magistrate Judge Sally Shushan of New Orleans ordered the federal government to assist in paying for nearly half of the the $1.67 million in court costs related to the trial of 2010 BP Gulf of Mexico oil spill, according to reports by

Shushan ordered the U.S. government to pay $839,581 on on Monday, August 18 because it acted as a plaintiff during the first and second phases of the civil trial. The U.S. government collaborated up with the plaintiffs’ steering committee which is comprised of attorneys who represent residents and businesses affected by the Gulf of Mexico oil spill.

The first phase of the civil trial, concluded in April 2013, had been all about finding out whom among the BP management and its contractors had been responsible for the April 20, 2010 explosion.

The second phase of the trial sought to find out exactly how much gallons of oil spilled in the Gulf. They concluded that the spill totaled 176 million gallons, enough to fill 266 Olympic-sized swimming pools.

The final phase, set to begin January of 2015, will determine the penalties BP must pay. If you have been affected by the spill, be sure to call our attorneys of the Williams Kherkher Law Group at 800-220-9341 to see if you might qualify for compensation related to this incident.

1 2 3 25

Williams Kherkher | 8441 Gulf Fwy #600 | Houston, TX 77017 | Phone: (713) 230-2200 | Toll Free: (800) 220-9341 | Directions